Innovation Pharmaceuticals Inc (IPIX)

[thefamilyman]

The problem with compassionate use in this context is that by the time they get Brilacidin approved for a particular patient, the virus has already over stimulated the immune system and done most, if not all, the damage it’s going to do. Brilacidin does have the other MOAs that might help. Brilacidin’s immunomodulatory capabilities might still help and it could also probably address bacterial pneumonia. But in a compassionate use situation, I expect that Brilacidin arrives too late for its virus killing capabilities to do much good. That is my fear when it comes to Brilacidin and compassionate use.